Search results
Secondary cancer: Why breast cancer survivors have a higher risk
Medical News Today· 7 days agoThe age of cancer diagnosis appears to affect second cancer risk, especially for women, as does economic status. In it, researchers from the University of Cambridge in England report that women ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoSAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the ...
Ayala Pharmaceuticals (NASDAQ:ADXS) Earns Sell Rating from Analysts at StockNews.com
ETF DAILY NEWS· 7 days agoStockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the stock. Ayala Pharmaceuticals ...
MD Anderson and Replay announce FDA clearance of IND application for first-in-class PRAME-targeted...
Newswise· 2 days agoMD Anderson and Replay today announced that the Food & Drug Administration (FDA) has issued a ‘safe to proceed’ for the Investigational New Drug (IND) appli
Eagles sweep Panthers in county rematch
The Herald Bulletin, Anderson, Ind. via Yahoo Sports· 7 days agoApr. 24—ELWOOD — At least it was dry the second time around. Less than two weeks after barely finishing their Madison County first-round match on a chilly and damp evening, Frankton returned ...
Critical Survey: Coeptis Therapeutics (COEP) versus The Competition
ETF DAILY NEWS· 7 days agoCoeptis Therapeutics (NASDAQ:COEP – Get Free Report) is one of 289 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We ...
Kura Oncology, Inc. (NASDAQ:KURA) Stock Holdings Lessened by Mirae Asset Global Investments Co. Ltd.
ETF DAILY NEWS· 6 days agoMirae Asset Global Investments Co. Ltd. lessened its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 5.7% in the fourth quarter, according to the company in its most ...
How Big Pharma Is Taking A Page Out Of Novartis' Playbook
Investor's Business Daily· 6 days agoNovartis (NVS) blazed a trail for treating cancer with targeted radiopharmaceuticals, a treatment that sends radiation directly to cancer cells. Novartis' prostate cancer ...
ImmunityBio Inc. Drug Approved By FDA
The Post-Journal· 7 days agoOn Monday, the Food and Drug Administration officially approved ANKTIVA, a treatment for unresponsive non-muscle invasive bladder cancer. “The FDA’s...
Targeting specific protein regions offers a new treatment approach in medulloblastoma
Newswise· 7 days agoBy studying EP300 and CBP, critical proteins in Group 3 medulloblastoma cells, scientists at St....
